A detailed history of Bristol John W & CO Inc transactions in Novartis Ag stock. As of the latest transaction made, Bristol John W & CO Inc holds 623,709 shares of NVS stock, worth $61.3 Million. This represents 1.17% of its overall portfolio holdings.

Number of Shares
623,709
Previous 624,923 0.19%
Holding current value
$61.3 Million
Previous $66.5 Million 7.83%
% of portfolio
1.17%
Previous 1.1%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$106.13 - $120.89 $128,841 - $146,760
-1,214 Reduced 0.19%
623,709 $71.7 Million
Q2 2024

Aug 14, 2024

SELL
$92.57 - $107.37 $1.26 Million - $1.46 Million
-13,635 Reduced 2.14%
624,923 $66.5 Million
Q1 2024

May 01, 2024

SELL
$95.27 - $108.47 $399,848 - $455,248
-4,197 Reduced 0.65%
638,558 $61.8 Million
Q4 2023

Jan 29, 2024

SELL
$92.27 - $101.54 $3.01 Million - $3.32 Million
-32,654 Reduced 4.83%
642,755 $64.9 Million
Q3 2023

Nov 07, 2023

SELL
$94.73 - $105.13 $674,572 - $748,630
-7,121 Reduced 1.04%
675,409 $68.8 Million
Q2 2023

Jul 28, 2023

SELL
$92.52 - $104.91 $415,507 - $471,150
-4,491 Reduced 0.65%
682,530 $68.9 Million
Q1 2023

Apr 14, 2023

BUY
$80.03 - $92.81 $305,554 - $354,348
3,818 Added 0.56%
687,021 $63.2 Million
Q4 2022

Jan 17, 2023

BUY
$75.55 - $92.52 $267,220 - $327,243
3,537 Added 0.52%
683,203 $0
Q3 2022

Oct 31, 2022

SELL
$74.61 - $87.26 $763,111 - $892,495
-10,228 Reduced 1.48%
679,666 $51.7 Million
Q2 2022

Aug 02, 2022

SELL
$80.52 - $93.75 $1.51 Million - $1.76 Million
-18,724 Reduced 2.64%
689,894 $58.3 Million
Q1 2022

May 10, 2022

SELL
$80.11 - $90.62 $1.35 Million - $1.53 Million
-16,862 Reduced 2.32%
708,618 $62.2 Million
Q4 2021

Jan 31, 2022

SELL
$79.7 - $88.13 $698,490 - $772,371
-8,764 Reduced 1.19%
725,480 $63.5 Million
Q3 2021

Oct 29, 2021

SELL
$81.78 - $95.14 $901,542 - $1.05 Million
-11,024 Reduced 1.48%
734,244 $60 Million
Q2 2021

Jul 23, 2021

SELL
$85.24 - $94.15 $492,346 - $543,810
-5,776 Reduced 0.77%
745,268 $68 Million
Q1 2021

Apr 27, 2021

SELL
$83.5 - $98.47 $307,363 - $362,468
-3,681 Reduced 0.49%
751,044 $64.2 Million
Q4 2020

Feb 05, 2021

SELL
$78.07 - $94.43 $85,642 - $103,589
-1,097 Reduced 0.15%
754,725 $71.3 Million
Q3 2020

Oct 26, 2020

BUY
$82.14 - $91.0 $348,191 - $385,749
4,239 Added 0.56%
755,822 $65.7 Million
Q2 2020

Aug 18, 2020

SELL
$80.93 - $91.1 $1.34 Million - $1.51 Million
-16,598 Reduced 2.16%
751,583 $65.6 Million
Q1 2020

May 01, 2020

SELL
$70.67 - $99.01 $699,845 - $980,496
-9,903 Reduced 1.27%
768,181 $63.3 Million
Q4 2019

Jan 21, 2020

SELL
$84.35 - $95.37 $200,753 - $226,980
-2,380 Reduced 0.3%
778,084 $73.7 Million
Q3 2019

Oct 15, 2019

SELL
$85.54 - $94.26 $387,410 - $426,903
-4,529 Reduced 0.58%
780,464 $67.8 Million
Q2 2019

Oct 16, 2019

BUY
$75.4 - $92.8 $1.06 Million - $1.31 Million
14,070 Added 1.83%
784,993 $71.7 Million
Q2 2019

Aug 07, 2019

SELL
$75.4 - $92.8 $1.69 Million - $2.08 Million
-22,421 Reduced 2.83%
770,923 $70.4 Million
Q1 2019

Oct 16, 2019

BUY
$75.32 - $86.15 $1.07 Million - $1.22 Million
14,170 Added 1.82%
793,344 $76.3 Million
Q1 2019

Apr 12, 2019

SELL
$75.32 - $86.15 $1.35 Million - $1.54 Million
-17,862 Reduced 2.24%
779,174 $74.9 Million
Q4 2018

Oct 16, 2019

BUY
$73.66 - $82.02 $1.04 Million - $1.16 Million
14,170 Added 1.81%
797,036 $68.4 Million
Q4 2018

Feb 07, 2019

SELL
$73.66 - $82.02 $4.53 Million - $5.05 Million
-61,516 Reduced 7.29%
782,866 $67.2 Million
Q3 2018

Oct 15, 2018

SELL
$66.94 - $77.43 $621,404 - $718,782
-9,283 Reduced 1.09%
844,382 $72.8 Million
Q2 2018

Aug 20, 2018

BUY
$64.91 - $73.36 $146,891 - $166,013
2,263 Added 0.27%
853,665 $64.5 Million
Q1 2018

May 11, 2018

SELL
$70.39 - $84.15 $921,757 - $1.1 Million
-13,095 Reduced 1.51%
851,402 $68.8 Million
Q4 2017

Jan 11, 2018

SELL
$72.33 - $77.64 $2.97 Million - $3.19 Million
-41,089 Reduced 4.54%
864,497 $72.6 Million
Q3 2017

Oct 13, 2017

SELL
$74.14 - $77.27 $2.74 Million - $2.86 Million
-36,974 Reduced 3.92%
905,586 $77.7 Million
Q2 2017

Aug 14, 2017

BUY
N/A
942,560
942,560 $78.7 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Bristol John W & CO Inc Portfolio

Follow Bristol John W & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bristol John W & CO Inc , based on Form 13F filings with the SEC.

News

Stay updated on Bristol John W & CO Inc with notifications on news.